NRGene Technologies Ltd (NRGN.TA)
- Previous Close
256.10 - Open
256.10 - Bid 250.00 x --
- Ask 263.80 x --
- Day's Range
250.00 - 256.00 - 52 Week Range
226.40 - 453.40 - Volume
2,000 - Avg. Volume
4,606 - Market Cap (intraday)
32.519M - Beta (5Y Monthly) -0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-0.95 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
www.nrgene.com29
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NRGN.TA
View MorePerformance Overview: NRGN.TA
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NRGN.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NRGN.TA
View MoreValuation Measures
Market Cap
32.60M
Enterprise Value
28.77M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.98
Price/Book (mrq)
2.33
Enterprise Value/Revenue
6.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-260.39%
Return on Assets (ttm)
-24.22%
Return on Equity (ttm)
-60.27%
Revenue (ttm)
1.29M
Net Income Avi to Common (ttm)
-3.36M
Diluted EPS (ttm)
-0.95
Balance Sheet and Cash Flow
Total Cash (mrq)
1.37M
Total Debt/Equity (mrq)
7.19%
Levered Free Cash Flow (ttm)
-3.02M